Drug Profile
PF 184562
Alternative Names: PF-00184562Latest Information Update: 15 Jul 2011
Price :
$50
*
At a glance
- Originator Pfizer
- Class Antipsychotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 15 Jul 2011 Discontinued - Phase-I for Schizophrenia in USA (PO)
- 01 Oct 2005 Phase-I clinical trials in Schizophrenia in USA (PO)